Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3479811 A
Publication typeGrant
Publication dateNov 25, 1969
Filing dateNov 29, 1967
Priority dateNov 29, 1967
Publication numberUS 3479811 A, US 3479811A, US-A-3479811, US3479811 A, US3479811A
InventorsHarold A Walters
Original AssigneeDow Chemical Co
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Yarn and method of making the same
US 3479811 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

Nov. 25, 1969 H. A. WALTERS 3,479,811

YARN AND METHOD OF MAKING THE SAME Filed Nov. 29, 1967 INVENTOR. Hora/0 4. W0 fleas nited States Patent 3,479,811 YARN AND METHOD 0r MAKING THE SAME Harold A. Walters, Beaverton, Mich, assignor to The Dow Chemical Company, Midland, Mich, a corporation of Delaware Filed Nov. 29, 1967, Ser. No. 686,656 Int. Cl. D02g 3/22, 3/36; 132% 7/20 US. Cl. 57-153 12 Claims ABSTRACT OF THE DISCLOSURE Expandable microspheres are incorporated in a thread or yarn, subsequently heated to expand the microspheres and bulk the yarn. Bulking of the yarn after weaving or sewing provides tightly woven fabric or locked-in sewing thread.

This invention relates to treated yarn and a method, and more particularly relates to the incorporation of expandable microspheres into textile yarns.

The bulking of yarns has been accomplished by various means. Fabrics have been impregnated with expanded and expandable microspheres. However, such impregnation is usually carried out after the weaving or other intertwining process has been completed. Oftentimes, it IS desirable that the yarns expand after being formed or incorporated into an article to provide what appears to be a tighter weave or otherwise secure and/ or interlock the yarn with its adjacent neighbors.

It would be advantageous if there were available a method and yarn which would form apparently relatively densely woven fabric without the necessity of weaving tightly.

It would also be beneficial if there were available a sewing thread which could be subsequently expanded after installation in a desired location.

It would also be desirable if there were avialable an improved method for bulking yarn.

These benefits and other advantages in accordance with the present invention are achieved by providing a yarn of a fibrous nature, impregnating the yarn with a dispersion containing expandable synthetic resinous microspheres which comprise a synthetic thermoplastic resinous wall and a distinct and separate liquid phase of a volatile expanding agent, subsequently disposing said microspheres within the yarn in a desired location, heating the yarn to a temperature sufiicient to cause expansion of the microspheres, thereby causing bulking of the yarn.

Also contemplated within the scope of the present invention is a yarn of a fibrous nature containing therein a plurality of synthetic resinous thermoplastic microspheres having a distinct and separate liquid phase therein, the microspheres being capable of expanding on heating to a diameter substantially greater than the original diameter of the microsphere.

Further features and advantages of the present invention will become more apparent from the following specication when taken in connection with the drawing wherein:

FIGURE 1 is a schematic enlarged representation of a yarn in accordance with the present invention.

FIGURE 2 is a schematic cross-sectional representation of a fabricated article in accordance with the invention.

FIGURE 3 is a schematic representation of a yarn having expanded microspheres therein.

In FIGURE 1 there is depicted a schematic representation of a yarn of a fibrous nature generally indicated by the reference numeral 10. The yarn 10 comprises a plurality of fibers or filaments 11 disposed in generally parallel adjacent relationship. A plurality of expandable syn- 3,479,811 Patented Nov. 25, 1969 'ice thetic resinous microspheres 12 are disposed in interstitial spaces 13 between the adjacent filaments 11. The microspheres 12 consist of a synthetic resinous thermoplastic hollow spherical shell containing a distinct and separate liquid phase of a blowing agent therein. Such expandable microspheres are well known in the art and are set forth in Belgian Patent 641,711.

In FIGURE 2 there is represented a schematic sectional view of a fabric 20 prepared from yarn in accordance with the present invention. The fabric 20 comprises a first set of generally parallel yarns 21 and a second set of generally parallel yarns 22 disposed generally in angular relationship to the set 21 and interwoven therewith. The dotted lines indicate the configuration of the yarns 21 and 22 after being subjected to heat sufiicient to cause the microspheres contained within the filaments to expand.

In FIGURE 3 there is depicted a portion of an expanded yarn 25 which has been removed from a fabric structure after expansion of the yarn. The yarn 25 has unexpanded or locking portions 26 and 27 arising from mechanical restraint during microspheres expansion.

A wide variety of yarns may be employed in the practice of the present invention such as threads, cordage and the like prepared from cotton, silk, jute, sisal, hemp, linen and wool, as Well as synthetics such as vinylidene chloride polymer multifilament, nylon, polyacrylonitrile, polyethylene, terephthalate, polypropylene, polyvinyl chloride, viscose rayon and blends of natural fibers, synthetic fibers as well as blends of natural and synthetic fibers.

It is critical to the present invention that the yarn define accessible void spaces between the fibers or filaments and be capable of expansion; that is, separation of the fibers or filaments sufiicient to admit microspheres into the interstitial spaces. Most yarns meet these requirements. A few yarns have been treated with a coating or bonding material or by heat treatment to a degree sufiicient to prevent such expansion. A wide variety of expandable microspheres are known and described in Belgian Patent 641,711. Generally, the particular nature of the microsphere is not critical. However, it is generally desirable to select a heat expanding microsphere having a composition which permits expansion at a temperature appropriate to the yarn employed; that is, one should not employ a microsphere which expands at a temperature above a temperature at which the strength or quality of the yarn or thread being treated is impaired such as by de-orientation, shrinkage, embrittlement or the like.

Oftentimes it is desirable to apply the microspheres to the yarn in combination with an adhesive material which promotes adhesion of the microspheres in the unexpanded form and subsequently in the expanded form to the surface of the fibers or filaments making up the yarn. Such adhesives or binders are well known and some are described in Belgian Patent 641,711. If, due to the particular nature of the yarn, an adhesive or binder is required, it is essential that one that is employed be inert to the expandable microspheres; that is, the binder must not destroy the structure of the microsphere. Typical binders or adhesives which are employed are synthetic resinous latexes or colloidal dispersions which are film forming at temperatures at which the microspheres initially start to expand to temperatures well below ambient temperatures. The particular adhesive employed will depend on the yarn, the characteristics required in the finished yarn such as friction, stiffness and the like. Selection of such adhesives is well within the skill of the art. Film forming synthetic resinous dispersions, such as polymers of styrene and butadiene such as a polymer of 70 parts by weight styrene and 30 parts by weight butadiene, are eminently satisfactory for many purposes, as are film forming vinylidene chlo-' ride polymers in aqueous colloidal dispersion such as a polymer of 85 weight percent vinylidene chloride and 15 weight percent acrylonitrile; water-soluble synthetic resins such as polyacrylic acid; water or alcohol soluble resins such as hydroxypropyl methyl cellulose; thermosetting resins such as the epoxy resins and the like. Beneficially in many instances, the addition of an adhesive may be omitted particularly with sized synthetic resinous yarns which have outer surfaces coated with a resin which softens or becomes tacky at temperatures of about 100 to 125 C., such as a polymer of 72 weight percent ethylene and 28 weight percent acrylic acid.

Beneficially in the practice of the present invention, the expandable synthetic resinous microspheres may be incorporated Within the yarn by a variety of techniques including immersion of the yarn in a liquid suspension of expandable microspheres. Beneficially, a tow of such yarns is impregnated by spraying, dipping, rolling, brushing or other conventional liquid-applying means. One particularly advantageous method of preparing a yarn impregnated with expandable microspheres is to pass the yarn to be coated through a bath and subsequently doctor the excess material therefrom by means of a perforated rubber diaphragm.

By way of further illustration, a polymerization re actor equipped with an agitator is charged with 100 parts of deionized water and 15 parts of a 30 weight percent colloidal silica dispersion in water. The colloidal silica dispersion is 30 weight percent solids and available under the trade name of Ludox HS. To this mixture is added 2.5 parts of a 10 weight percent aqueous solution of a copolymer prepared from diethanol amine and adipic acid in equimolar proportions by carrying out a condensation: reaction to give a product having a viscosity of about 100 centipoises at 25 C. One part of a solution containing 2.5 weight percent potassium dichromate is added. The pH of the aqueous solution is adjusted to 4 with hydrochloric acid. A methyl methacrylate and acrylonitrile mixture is utilized as the monomer in a proportion of 4:1, respectively. An oil phase mixture is prepared utilizing 100 parts of the foregoing monomer mixture and containing 35 weight percent neopentane and 0.1 part of benzoyl peroxide as a catalyst. The oil phase mixture is added to the water phase with violent agitation supplied by a blade rotating at a speed of about 10,000 revolutions per minute. The reactor is immediately sealed and a portion of the contents sampled to determine the particle size. The droplets appear to have diameters of from about 2 to about 10 microns. After the initial dispersion, the reaction mixture is maintained at a temperature of about 80 C. for a period of 24 hours. At the end of this period, the temperature is lowered and the reaction mixture has the appearance of a white, milky liquid similar to a chalkwhite milk. A portion of the mixture is filtered to remove the beads and the beads subsequently dried in an air oven at a temperature of about 30 C. A portion of the dried beads are heated in an air oven at a temperature of 150 C. for about 3 minutes. Upon heating, the beads show a marked increase in volume. Microscpoic examination of the beads prior to foaming indicates beads having diameters of from about 2 to about 10 microns and having dispersed therein a distinct spherical zone which appears to contain liquid and a small Vapor space. The beads which have been heated are examined micro scopically and are found to have diameters of from about 2 to times the diamter of the original bead and a relatively thin, transparent wall and a gaseous center, i.e., a monocell. The remaining portion of the chalk-White material is filtered to provide a wet'filter cake containing about 29.6 Weight percent expandable microspheres. A coating mixture is prepared by admixing 81.1 parts by weight of a polymer latex of 60 weight percent styrene and 40 weight percent butadiene which is 49.3 weight percent solids, 2.7 parts by weight of a 25 weight percent aqueous solution of sodium dodecyl diphenyl oxide disulfonate, 207 parts by weight of water and 16.2 parts by weight of a 5 weight percent aqueous solution of a thickening agent commercially available under the trade designation of Acrysol GS. The coating solution is then applied to a plurality of yarns by immersing the yarns and doctoring olf excess coating material by drawing through an opening formed by perforating a thin rubber diaphragm with a needle. The coated yarn is air-dried at a temperature of about 60 C. Portions of the thread are subsequently formed by heating in an air oven at 135 C. The yarns employed and the results are as follows:

YARN 1 A No. 40 cotton thread is coated with a dry coating weight of 0.0846 gram per 10 feet and after expansion increases to about twice its original diameter.

YARN 2 A No. 50 cotton thread is coated with a dry coating weight of 0.0534 gram per 10 feet and after expansion increases to about twice its original diameter.

YARN 3 A sized silk thread manufactured by Belding and Corticelli is coated with a dry coating weight of 0.1336 gram per 10 feet and after expansion increases to about 50 percent of its original diameter with a substantial increase in thickness.

YARN 4 A nylon thread designated as Coats and Clark Taslan textured nylon thread is coated with a dry coating weight of 0.042 gram per 10 feet and after expansion of the microspheres shows localized areas of individual fibers curled and standing out from the body of the thread.

YARN 5 Coats and Clark No. 333 wool yarn requires a dry coating weight of 0.0289 gram per 10 feet and on expansion increases its diameter about 2.5 times.

Other foamable microsphere coating compositions are prepared as follows:

COMPOSITION A 106.6 parts by weight of expandable microspheres having a polymer shell which is a polymer of weight percent vinylidene chloride and 20 weight percent acrylo nitrile containing 35 weight percent neopentane based on the combined weight of polymer and neopentane, the filter cake containing 25 weight percent Water, parts by weight of water, 40 parts by weight of a 60-40 copolymer of styrene and butadiene latex, 50 Weight percent solids, 78.3 parts by weight of a 5 weight percent solution of the sodium salt of polyacrylic acid.

COMPOSITION C Ninety parts by weight of a wet filter cake of expandable microspheres having a polymer shell of 60 weight percent styrene and 40 weight percent acrylonitrile copolymer containing 35 weight percent neopentane based on the combined weight of the polymer and neopentane and 25 parts by weight water, 103 parts by weight water, 60.4 parts by weight of an aqueous latex, 50 percent solids of a polymer of 85 weight percent vinyl chloride, weight percent butyl acrylate and 5 weight percent acylic acid, 10 parts by weight of a 10 weight percent solution of hydroxyethyl cellulose.

COMPOSITION D Ninety-four parts by weight of a wet filter cake of expandable microspheres having a polymer shell of 80 weight percent methyl methacrylate and weight percent methyl acrylate and weight percent neopentane based on the combined weight of the neopentane and the copolymer and 25 weight percent water, 100 parts by weight water, parts by weight of a weight percent solids latex of a polymer of weight percent styrene and 40 weight percent butadiene, 78.3 parts by weight of a 5 Weight percent aqueous solution of the sodium salt of polyacrylic acid.

Similar beneficial and advantageous results are obtained when cotton, silk, wool and nylon threads are coated With compositions A, B, C, and D. Use of coated or impregnated threads prepared in accordance with the present invention is susceptible of being embodied with 1y heated to a temperature sufficient to cause expansion, substantially eliminates the need for knotting or tying of the thread at either end thereof, as after heating the thread to cause expansion, it is difiicult to remove the thread from a woven fabric. Similar advantages are achieved when expandable thread of the present invention is employed for attaching buttons. Fabric woven from the expandable yarns prepared in accordance with the present invention and heat treated to expand the microspheres provides a dense-appearing fabric much tighter than original weave and with significant antiravelling properties.

As is apparent from the foregoing specification, the present invention is susceptible of being embodied with various alterations and modifications which may differ particularly from those that have been described in the preceding specification and description. For this reason, it is to be fully understood that all of the foregoing is intended to be merely illustrative and is not to be construed or interpreted as being restrictive or otherwise limiting of the present invention.

What is claimed is:

1. A method of providing a bulked yarn of a fibrous nature comprising providing a yarn,

impregnating the yarn with a dispersion containing synthetic resinous microspheres, the microspheres comprising a synthetic thermoplastic resinous wall and a distinct and separate liquid phase of a volatile expanding agent which is a non-solvent for the resinous wall, subsequently disposing said microspheres within the yarn in a desired location,

heating the yarn to a temperature sufiicient to cause expansion of the microspheres, thereby causing bulking of the yarn.

2. The method of claim 1 wherein the microspheres are disposed within the yarn by dispersion from a liquid suspension of microspheres.

3. The method of claim 2 including the step of incorporating an adhesive material within the microsphere dispersion.

4. The method of claim 3 including the step of removing the liquid of the dispersion from the yarn prior to heating of the yarn.

5. The method of claim 1 including the step of intertwining the yarn with a plurality of yarns prior to the expansion thereof.

6. The method of claim 5 wherein the intertwining of the yarn is accomplished by weaving.

7. An improved textile yarn of a generally parallel fibrous nature, the yarn containing dispersed therethrough a plurality of synthetic resinous thermoplastic microspheres having a distinct and separate liquid phase therein, the microspheres being capable of expanding on heating to a diameter substantially greater than the original diameter of the microspheres and thereby bulking the yarn.

8. The filament of claim 7 intertwined with a plurality of like yarns.

9. The filament of claim 8 wherein the yarn is cotton.

10. The yarn of claim 8 wherein the yarn is silk.

11. The yarn of claim 8 wherein the yarn is nylon.

12. The yarn of claim 8 including an adhesive binding the microspheres to the yarn.

References Cited UNITED STATES PATENTS 2,744,291 5/1956 Stastny et al. 264-53 2,815,559 12/1957 Robinson 57164 XR 2,940,871 6/1960 Smith-Johannsen 117-138.8 3,100,926 8/1963 Richmond 28--75 3,154,604 10/1964 McMillan 264-53 XR 3,359,130 12/1967 Goldman 264-53 XR 3,372,215 3/1968 Muirhead et al. 264-53 MERVIN STEIN, Primary Examiner WERNER H. SCHROEDER, Assistant Examiner US. Cl. X.R.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2744291 *Apr 16, 1952May 8, 1956Basf AgProduction of porous shaped articles from thermoplastic materials
US2815559 *Aug 3, 1953Dec 10, 1957Robinson Thread CompanyCellular synthetic fibre thread and a method of making the same
US2940871 *Aug 5, 1955Jun 14, 1960S J Chemical CompanyComposition and method of making microporous products
US3100926 *Jun 28, 1960Aug 20, 1963Electric Storage Battery CoMethod of producing expanded fabric-like material
US3154604 *Mar 19, 1956Oct 27, 1964Dow Chemical CoMethod for forming articles comprising expanded thermoplastic resinous materials
US3359130 *Nov 12, 1963Dec 19, 1967Papex CorpDouble shelled foamable plastic particles
US3372215 *Mar 16, 1966Mar 5, 1968Shell Oil CoProduction of expandable polymer particles
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3936335 *Nov 1, 1974Feb 3, 1976Scientific Anglers, Inc.Process for producing a buoyant fishing line
US5205290 *Apr 5, 1991Apr 27, 1993Unger Evan CKits for imaging gastrointestinal disorders; anti-gas; biocompatible polymers, thickeners
US5277957 *Sep 9, 1991Jan 11, 1994Orcon CorporationFilm reinforced with yarn coated with hot melt adhesive
US5281408 *Jan 19, 1993Jan 25, 1994Unger Evan CAdministering a contrast agent and scanning using tomography to form images
US5334418 *Sep 3, 1993Aug 2, 1994Reeves Brothers, Inc.Applying matrix material containing cells to fabric substrate to surround and impregnate, curing
US5364683 *Feb 14, 1992Nov 15, 1994Reeves Brothers, Inc.Compressible printing blanket and method of making same
US5441813 *Aug 16, 1994Aug 15, 1995Sumitomo Electric Industries, Ltd.Blend of photopolymer and heat expansable encapsulating hollow spheres
US5456900 *Sep 7, 1993Oct 10, 1995Unger; Evan C.Low density microspheres and their use as contrast agents for computed tomography
US5486402 *Oct 12, 1994Jan 23, 1996Reeves Brothers, Inc.Printing blanket having printing face surface profile within specified roughness range
US5527521 *Jun 1, 1995Jun 18, 1996Imarx Pharmaceutical Corp.Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications
US5547656 *May 24, 1995Aug 20, 1996Imarx Pharmaceutical Corp.Low density microspheres and their use as contrast agents for computed tomography, and in other applications
US5549968 *Mar 8, 1994Aug 27, 1996Reeves Brothers, Inc.Compressible fabric substrate
US5562985 *Jun 1, 1995Oct 8, 1996Sumitomo Electric Industries, Ltd.Communication line material
US5733572 *Nov 29, 1994Mar 31, 1998Imarx Pharmaceutical Corp.Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5736121 *May 19, 1995Apr 7, 1998Imarx Pharmaceutical Corp.Administering stabilized aqueous suspension of gaseous precursor to patient, allowing phase transition form liquid to gas, scanning
US5769080 *Feb 22, 1994Jun 23, 1998Dupont Merck Pharmaceutical CompanyGas filled liposomes and stabilized gas bubbles and their use as ultrasonic contrast agents
US5770222 *Jun 7, 1995Jun 23, 1998Imarx Pharmaceutical Corp.Therapeutic drug delivery systems
US5776429 *Apr 30, 1996Jul 7, 1998Imarx Pharmaceutical Corp.Method of preparing gas-filled microspheres using a lyophilized lipids
US5830430 *Feb 21, 1995Nov 3, 1998Imarx Pharmaceutical Corp.Cationic lipids and the use thereof
US5846517 *Jan 30, 1997Dec 8, 1998Imarx Pharmaceutical Corp.Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US5853752 *Jun 6, 1995Dec 29, 1998Imarx Pharmaceutical Corp.Methods of preparing gas and gaseous precursor-filled microspheres
US5874062 *May 19, 1995Feb 23, 1999Imarx Pharmaceutical Corp.Medical diagnosis with fluorocarbons in microspheres
US5922304 *Mar 9, 1995Jul 13, 1999Imarx Pharmaceutical Corp.Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5985246 *Jul 8, 1997Nov 16, 1999Imarx Pharmaceutical Corp.Contrast agents for ultrasonic imaging and methods for preparing the same
US5997898 *Jun 6, 1995Dec 7, 1999Imarx Pharmaceutical Corp.Stabilized compositions of a sf6 gas and a phosphorylated fluorinated amphiphilic compound, contrast agents for ultrasound.
US6001335 *Jun 18, 1996Dec 14, 1999Imarx Pharmaceutical Corp.Synthesizing a lipid vesicle having a gas encapsulated therein for ultrasonic imaging, by subjecting a solvent-free composition of a gaseous precursor and lipid in aqueous medium to a first pressure, then a second lower pressure
US6028066 *Jul 2, 1997Feb 22, 2000Imarx Pharmaceutical Corp.For delivering higher concentrations of bioactive agents to improve efficacy of the bioactive agents
US6033645 *Jun 19, 1996Mar 7, 2000Unger; Evan C.Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6033646 *Feb 19, 1998Mar 7, 2000Imarx Pharmaceutical Corp.Method of preparing fluorinated gas microspheres
US6039557 *Apr 7, 1997Mar 21, 2000Imarx Pharmaceutical Corp.Apparatus for making gas-filled vesicles of optimal size
US6056938 *May 5, 1998May 2, 2000Imarx Pharaceutical Corp.Cationic lipids and the use thereof
US6071494 *Aug 28, 1998Jun 6, 2000Imarx Pharmaceutical Corp.Lipid, protein or polymer and a gas or gaseous precursor, in combination with a renal vasodilator.
US6071495 *Oct 2, 1997Jun 6, 2000Imarx Pharmaceutical Corp.Targeted gas and gaseous precursor-filled liposomes
US6071567 *Mar 25, 1992Jun 6, 2000Reeves Brothers, Inc.Compression printing
US6088613 *Jun 7, 1995Jul 11, 2000Imarx Pharmaceutical Corp.Method of magnetic resonance focused surgical and therapeutic ultrasound
US6090800 *May 6, 1997Jul 18, 2000Imarx Pharmaceutical Corp.Reaction product containing dexamethasone
US6117414 *Nov 10, 1997Sep 12, 2000Imarx Pharmaceutical Corp.Administering hydrophilic polymer covalently bonded to biocompatible lipid filled with perfluorocarbon of sulfur hexafluoride gas
US6120751 *Sep 8, 1997Sep 19, 2000Imarx Pharmaceutical Corp.Charged lipids and uses for the same
US6123923 *Dec 18, 1997Sep 26, 2000Imarx Pharmaceutical Corp.Optoacoustic contrast agents and methods for their use
US6139819 *Sep 17, 1997Oct 31, 2000Imarx Pharmaceutical Corp.Comprising lipid, protein, polymer and/or surfactant, and a gas, in combination with a targeting ligand; targeting ligand targets coagula, including emboli and/or thrombi, particularly in patients suffering from arrhythmic disorder
US6143276 *Mar 21, 1997Nov 7, 2000Imarx Pharmaceutical Corp.Methods for delivering bioactive agents to regions of elevated temperatures
US6146657 *Nov 1, 1996Nov 14, 2000Imarx Pharmaceutical Corp.Liposome filled with an insoluble gas and a soluble gas, wherein said liposome comprises phosphatidylcholine(s), phosphatidylethanolamine(s), and phosphatidic acid(s); use in ultrasonic or magnetic resonance imaging
US6231834Dec 2, 1997May 15, 2001Imarx Pharmaceutical Corp.Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6248274Sep 21, 1999Jun 19, 2001Playtex Products, Inc.Method of manufacturing a catamenial/tampon device
US6287638Nov 23, 1999Sep 11, 2001Reeves Brothers, Inc.Vulcanization
US6315981Mar 19, 1999Nov 13, 2001Imarx Therapeutics, Inc.Used for obtaining image of an internal region of humans
US6403056Mar 31, 2000Jun 11, 2002Imarx Therapeutics, Inc.Administering agent; applying ultrasonic frequency
US6414139Sep 3, 1996Jul 2, 2002Imarx Therapeutics, Inc.Silicon amphiphilic compounds and the use thereof
US6416740May 11, 1998Jul 9, 2002Bristol-Myers Squibb Medical Imaging, Inc.Acoustically active drug delivery systems
US6443898Jun 7, 1995Sep 3, 2002Imarx Pharmaceutical Corp.Therapeutic delivery systems
US6444660Feb 3, 2000Sep 3, 2002Imarx Therapeutics, Inc.Dexamethasone covalently bonded to a lipid moiety via a linking group
US6461586Jul 10, 2000Oct 8, 2002Imarx Therapeutics, Inc.Method of magnetic resonance focused surgical and therapeutic ultrasound
US6479034Jul 17, 1998Nov 12, 2002Bristol-Myers Squibb Medical Imaging, Inc.Method of preparing gas and gaseous precursor-filled microspheres
US6521211Feb 3, 1999Feb 18, 2003Bristol-Myers Squibb Medical Imaging, Inc.Methods of imaging and treatment with targeted compositions
US6528039Jun 18, 1997Mar 4, 2003Bristol-Myers Squibb Medical Imaging, Inc.Low density microspheres and their use as contrast agents for computed tomography and in other applications
US6537246Jun 18, 1997Mar 25, 2003Imarx Therapeutics, Inc.Oxygen delivery agents and uses for the same
US6548047Sep 15, 1997Apr 15, 2003Bristol-Myers Squibb Medical Imaging, Inc.Thermal preactivation of gaseous precursor filled compositions
US6551576Mar 31, 1998Apr 22, 2003Bristol-Myers Squibb Medical Imaging, Inc.Container with multi-phase composition for use in diagnostic and therapeutic applications
US6576220May 10, 2001Jun 10, 2003Imarx Therapeutics, Inc.Non-invasive methods for surgery in the vasculature
US6635205Jun 11, 2001Oct 21, 2003Playtex Products, Inc.Method of manufacturing a catamenial/tampon device
US6638767Dec 21, 2000Oct 28, 2003Imarx Pharmaceutical CorporationMethods for delivering compounds into a cell
US6688226Oct 3, 2001Feb 10, 2004Erminio Rossini, S.P.A.Sleeve for blanket cylinder of an indirect or offset printing machine and method of making said sleeve
US6716412Mar 21, 2001Apr 6, 2004Imarx Therapeutics, Inc.Methods of ultrasound treatment using gas or gaseous precursor-filled compositions
US6743779Apr 29, 1997Jun 1, 2004Imarx Pharmaceutical Corp.Methods for delivering compounds into a cell
US6773696Oct 25, 2002Aug 10, 2004Bristol-Myers Squibb Medical Imaging, Inc.Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
US6808720Jan 15, 2002Oct 26, 2004Imarx Therapeutics, Inc.Charged lipids and uses for the same
US6884407May 18, 2000Apr 26, 2005Bristol-Myers Squibb Pharma CompanyMethods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
US6998107Jun 10, 2004Feb 14, 2006Bristol-Myers Squibb Pharma Comapanycomprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
US7078015Nov 8, 2004Jul 18, 2006Imarx Therapeutics, Inc.Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue
US7083572Mar 26, 2002Aug 1, 2006Bristol-Myers Squibb Medical Imaging, Inc.Therapeutic delivery systems
US7105151Jan 6, 2003Sep 12, 2006Imarx Therapeutics, Inc.Oxygen delivery agents and uses for the same
US7329402Jan 13, 2003Feb 12, 2008Imarx Pharmaceutical Corp.Methods of imaging and treatment
US7344705Oct 18, 2005Mar 18, 2008Bristol-Myers Squibb Medical Imaging, Inc.Composition comprising low density microspheres
US7452551Oct 30, 2000Nov 18, 2008Imarx Therapeutics, Inc.Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a perfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
US7612033Mar 18, 2004Nov 3, 2009Imarx Pharmaceutical Corp.administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
US7780875Jan 13, 2006Aug 24, 2010Cinvention AgComposite materials containing carbon nanoparticles
US8084056Sep 22, 2003Dec 27, 2011Lantheus Medical Imaging, Inc.Useful as an ultrasonic contrast agent; making by dissolving a nonaqueous solvent in a lipid blend, then contacting the solution with an aqueous solution to form a lipid suspension
US8658205Aug 1, 2011Feb 25, 2014Lantheus Medical Imaging, Inc.Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US8685441Jul 23, 2013Apr 1, 2014Lantheus Medical Imaging, Inc.Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US8747892Jul 25, 2013Jun 10, 2014Lantheus Medical Imaging, Inc.Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE10104585A1 *Feb 1, 2001Aug 14, 2002Verseidag Indutex GmbhSchutzelement gegen ballistische Einwirkungen
EP0672883A1 *Feb 28, 1995Sep 20, 1995Niltar Trading S.A.Antitrauma packet
EP1423568A1 *Aug 1, 2002Jun 2, 2004Coating Innovations Pty. LimitedAlternative to viscose flocking
EP1609896A2May 31, 2005Dec 28, 2005Mathias BerlingerProcess for depositing microcapsules into multifilament yarn and the products produced
Classifications
U.S. Classification57/258, 57/351, 521/139, 521/56, 521/59, 57/297, 264/53, 521/140, 57/246, 521/134, 28/166, 57/250
International ClassificationD03D15/00, D02G1/00, D02G3/40
Cooperative ClassificationD10B2331/04, D10B2331/02, D10B2201/04, D10B2401/041, D10B2321/022, D03D15/00, D03D2700/014, D10B2321/041, D10B2401/08, D10B2201/02, D10B2201/06, D10B2211/04, D10B2321/10, D03D15/0027, D02G1/00, D02G3/40, D10B2201/24
European ClassificationD03D15/00, D03D15/00E, D02G1/00, D02G3/40
Legal Events
DateCodeEventDescription
Jun 30, 1987ASAssignment
Owner name: CASCO NOBEL AB, P.O. BOX 11010, S-100 61 STOCKHOLM
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:PIERCE & STEVENS CORP.;REEL/FRAME:004734/0075
Effective date: 19860911
May 6, 1981ASAssignment
Owner name: PIERCE & STEVENS CHEMICAL CORPORATION
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:DOW CHEMICAL COMPANY, THE;REEL/FRAME:003869/0545
Effective date: 19810504